Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-17

Clinical Trial Update: A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cortisol response to ACTH stimulation after Baxdrostat treatment versus placebo in adults with uncontrolled hypertension; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baxdrostat (Baxdrostat)

Snippet

Sponsor: AstraZeneca | Conditions: Uncontrolled Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2025-12-17